Literature DB >> 6305305

Calcific diseases. A concept.

H C Anderson.   

Abstract

New observations portray calcification processes as similar whether occurring normally or pathologically. Most forms of calcification are initiated by membranous organelles, ie, extracellular, calcifying "matrix vesicles" or intracellular mitochondria. Matrix vesicles promote calcification through calcium-binding phospholipids and phosphatase activity. Mitochondria use a forceful, inwardly directed Ca and phosphate transport mechanism. After mineral initiation, the proliferation of mineral crystals is dependent on regulatory factors, such as extracellular Ca2+ and PO4(3-) and other mineral inhibitors and promoters. Calcific diseases are defined as those in which (1) Ca uptake is early, (2) calcification is importantly related to dysfunction, and (3) the control of calcification may lead to decreased morbidity or enhanced diagnostic capability. Calcific diseases include such well-known entities as crystal deposition arthritis, atherosclerosis, calcific valvular sclerosis, tumor calcification, dental plaque, and dysfunctional calcification occurring in implanted cardiovascular devices.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6305305

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  25 in total

1.  Computerized Image Analysis of Clustered Microcalcifications on Mammography: Morphome- tric Comparison between Mammography and Pathology.

Authors: 
Journal:  Breast Cancer       Date:  1996-12-20       Impact factor: 4.239

2.  Membrane-associated crystallization of calcium oxalate in vitro.

Authors:  S R Khan; P N Shevock; R L Hackett
Journal:  Calcif Tissue Int       Date:  1990-02       Impact factor: 4.333

3.  Mechanism by which MLO-A5 late osteoblasts/early osteocytes mineralize in culture: similarities with mineralization of lamellar bone.

Authors:  C Barragan-Adjemian; D Nicolella; V Dusevich; M R Dallas; J D Eick; L F Bonewald
Journal:  Calcif Tissue Int       Date:  2006-11-14       Impact factor: 4.333

4.  Calcification of bovine pericardium used in cardiac valve bioprostheses. Implications for the mechanisms of bioprosthetic tissue mineralization.

Authors:  F J Schoen; J W Tsao; R J Levy
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

5.  Bisacylphosphonates inhibit hydroxyapatite formation and dissolution in vitro and dystrophic calcification in vivo.

Authors:  G Golomb; A Schlossman; H Saadeh; M Levi; J M Van Gelder; E Breuer
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

6.  TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify.

Authors:  K E Watson; K Boström; R Ravindranath; T Lam; B Norton; L L Demer
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

7.  Diosgenin attenuates vascular calcification in chronic renal failure rats.

Authors:  Jeganathan Manivannan; T R Barathkumar; Jeganathan Sivasubramanian; Pandian Arunagiri; Boobalan Raja; Elumalai Balamurugan
Journal:  Mol Cell Biochem       Date:  2013-02-20       Impact factor: 3.396

8.  High expression of genes for calcification-regulating proteins in human atherosclerotic plaques.

Authors:  C M Shanahan; N R Cary; J C Metcalfe; P L Weissberg
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

9.  Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene.

Authors:  D Fatkin; M E Christe; O Aristizabal; B K McConnell; S Srinivasan; F J Schoen; C E Seidman; D H Turnbull; J G Seidman
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

10.  Morphologic features and nuclide composition of infarction-associated cardiac myocyte mineralization in humans.

Authors:  V G Lockard; S Bloom
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.